Daniel Sharbel
Papers
2
Total Citations
28
H-Index
2
About
Daniel Sharbel is a head and neck surgeon whose research focuses on refining surgical approaches for oropharyngeal carcinoma, particularly in the context of HPV-positive disease. His work centers on two key areas: preventing life-threatening postoperative hemorrhage in transoral robotic surgery (TORS) and advancing surgical clinical trials for HPV-positive oropharyngeal squamous cell carcinoma (OPSCC). Sharbel’s most cited study, a systematic review and meta-analysis on transcervical arterial ligation to prevent bleeding after TORS (19 citations), provides critical evidence for a prophylactic technique that enhances patient safety in a high-risk procedure. His subsequent work on surgical clinical trials for HPV-positive OPSCC (9 citations) synthesizes the evolving landscape of treatment de-escalation, highlighting how surgery, radiation, and immunotherapy are being tested to reduce morbidity without compromising oncologic outcomes. By addressing both technical complications and trial design, Sharbel contributes to a paradigm shift toward less toxic, surgically driven care. His research is essential reading for surgeons and oncologists seeking to balance efficacy with quality of life in head and neck cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2Surgical clinical trials for HPV-positive oropharyngeal carcinoma9 citations · 2022